Candel Therapeutics, Inc.

Historical 13F Holders

Symbol
CADL
CUSIP
137404109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 137404109 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.0% 2/7/2025
Event 1/31/2025
RTW Investments, LP 13G
8.8% 5/15/2026
Event 3/31/2026
Paul B Manning 13D/A
7.9% 3/18/2026
Event 12/16/2024
BlackRock, Inc. 13G 6.6% 7/27/2026
Event 6/30/2026
Acorn Bioventures, L.P. 13G
5.2% 6/30/2025
Event 6/25/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Baker Bros. Advisors LP 13G/A
4.99% 5/15/2025
Event 3/31/2025
CVI Investments, Inc. 13G/A
0% 2/7/2025
Event 12/31/2024
Northpond Ventures, LP 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 55 16.2 M $170M
2026 Q2 138 50.4 M $519M
2026 Q1 115 43.4 M $213M
2025 Q4 84 23.6 M $134M
2025 Q3 82 22.7 M $116M
2025 Q2 81 23.0 M $117M
2025 Q1 85 21.2 M $120M
2024 Q4 72 18.0 M $156M
2024 Q3 53 6.69 M $46.4M
2024 Q2 48 5.96 M $37.0M
2024 Q1 21 3.78 M $5.97M
2023 Q4 23 4.03 M $5.92M
2023 Q3 21 5.26 M $4.86M
2023 Q2 21 5.37 M $6.77M
2023 Q1 22 5.48 M $7.44M
2022 Q4 22 5.42 M $9.70M
2022 Q3 26 6.08 M $19.1M
2022 Q2 24 6.35 M $20.6M
2022 Q1 24 6.67 M $34.0M
2021 Q4 21 6.95 M $54.4M
2021 Q3 13 4.88 M $52.9M